Respiree provides end-to-end cardio-respiratory monitoring and analytics platform solutions that can be connected between hospitals and homes via API bridges.
BATCH 0 - APAC
BATCH 0 - APAC
Location: Singapore
Employees: 11-50
Total raised: $11.6M
Investors 2
| Date | Name | Website |
| - | Startup Cr... | startupcre... |
| - | Purpose Ve... | purposeven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2025 | Series A | $11.6M | ClavystBio |
Mentions in press and media 11
| Date | Title | Description |
| 08.12.2025 | RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION | SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B software-as-a-medical device (SaMD). The solution is design... |
| 14.11.2025 | TMCi names 11 global startups to latest HealthTech Accelerator cohort | Texas Medical Center Innovation has named 11 medtech startups from around the world to its latest HealthTech Accelerator cohort. Members of the accelerator's 19th cohort will participate in the six-month program, which kicked off this month... |
| 13.11.2025 | America's first Ismaili Center set to open in Houston in December | The long-awaited Ismaili Center, Houston is set to open to the public next month. The 11-acre site has been painstakingly designed and constructed to offer indoor and outdoor public spaces for Houstonians to enjoy, connect, and engage. As t... |
| 12.08.2025 | Singapore’s Respiree closed $11.6 M Series A financing from We Venture Capital, ClavystBio | We Venture Capital and ClavystBio led a $11.6 million Series A financing round that was successfully closed by Respiree, a Singapore-based health tech company that produces artificial intelligence (AI) platforms to manage disease progressio... |
| 24.07.2025 | Deals in brief: Respiree raises Series A funding, HeyMax expands with Krip acquisition, latest China deals, and more | Respiree raises Series A funding to scale health monitoring AI Respiree, a health tech company founded in Singapore, has raised USD 11.6 million in a Series A funding round co-led by We Venture Capital and ClavystBio. Other participants inc... |
| 24.07.2025 | ClavystBio co-anchors $11.6m funding in healthtech Respiree | - |
| 26.02.2025 | RESPIREE SECURES SINGAPORE HSA CLEARANCE FOR PEDIATRIC EXPANSION OF CARDIO-RESPIRATORY WEARABLE AND FOR ITS NEW EHR STREAMLINED PLATFORM | SINGAPORE, Feb. 26, 2025 /PRNewswire/ -- AI/ML health tech startup Respiree has received clearance from the Health Sciences Authority (HSA) to extend its RS001 cardio-respiratory wearable to pediatric populations. This clearance also enable... |
| 17.09.2024 | Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring | With this collaboration, Respiree's patient monitoring solution will be made available for healthcare professionals in APAC through a pilot program using Roche's blood glucose monitoring system. The goal is to simplify clinical workflows an... |
| 09.03.2023 | DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE | SINGAPORE, March 9, 2023 /PRNewswire/ -- Digital therapeutics startup Respiree has received the United States Food and Drug Administration's 510(k) clearance for its RS001 cardio-respiratory wearable. Illustrative Image of Respiree™’s RS001... |
| 08.03.2022 | ASTAR healthtech startup spin-off bags $3.4m seed funding | InvestmentsNewsStartups Aditya Hadi Pratama · 9 Mar 2022 · 1 min readASTAR healthtech startup spin-off bags $3.4m seed funding Respiree, a Singapore-based healthtech startup, has raised S$4.7 million (around US$3.4 million) in a seed round ... |
Show more